☰
☰
Home (All News)
Finance News
Interviews
Stock Watch
Company News
Funds Management
Copyright Finance TV Pty Ltd
ABN 31 117 966 328
Use of Our Content
Disclaimer
Privacy Policy
Alterity Therapeutics (ASX:ATH) - Webinar Presentation
09/08/2024 14:30:00
This video is not supported on your device. Click here for the original version.
Dr David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.